- Description
- Specifications
Catalog #: IHA-017
Description:
Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Tokio/53/99. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.
Purity:
Greater than 90.0% as determined byAnalysis by SDS-PAGE.
Formulation:
The B/Tokio/53/99solution (1.7mg/ml) contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.
Stability:
B/Tokio/53/99 although stable 4 °C for 4 weeks, should be stored below -18 °C.
Please prevent freeze-thaw cycles.
Activity:
Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA.
Physical Appearance:
Sterile Filtered colorless solution.
Inactivation:
Thimerosal and beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
